About: covid:PMC7097833

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7097833 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Ippolito, Giuseppe Nicastri, Emanuele Petrosillo, Nicola D’Offizi, Gianpiero Lepore, Luciana Marchioni, Luisa Murachelli, Silvia Antinori, Andrea Mondi, Annalisa Palmieri, Fabrizio Ascoli Bartoli, Tommaso
is schema:about of	named entity 'Recommendations' named entity 'COVID-19' named entity 'INSTITUTE' named entity 'INFECTIOUS DISEASES' named entity '80%' named entity 'NATIONAL' named entity 'National Institute' named entity 'G6PD deficiency' named entity 'intravenously' named entity 'Hypersensitivity reaction' named entity 'chloroquine' named entity 'Porphyria' named entity 'anaphylactoid reaction' named entity 'acute respiratory infection' named entity 'Lopinavir/ritonavir' named entity 'Virologic' named entity 'pneumonia' named entity 'QT prolongation' named entity 'clinical symptoms' named entity 'IL-6' named entity 'Antiviral therapy' named entity 'health-care' named entity 'symptom' named entity 'Antiviral therapy' named entity 'COVID' named entity 'China' named entity 'drug-drug interactions' named entity 'chloroquine' named entity 'inflammation' named entity 'drug-drug interactions' named entity 'COVID' named entity 'China' named entity 'case report' named entity 'adverse effects' named entity 'fever' named entity 'liver function tests' named entity 'Italy' named entity 'IL-6 receptor' named entity 'adverse effects' named entity 'chloroquine' named entity 'neutrophil' named entity 'heart failure' named entity 'Italy' named entity 'cardiac failure' named entity 'D-dimer' named entity 'COVID' named entity 'U.S.' named entity 'Antinori' named entity 'vital functions' named entity 'COVID-19 in the United States' named entity 'aplastic anemia' named entity 'Stevens-Johnson syndrome' named entity 'Galati' named entity 'seizure threshold' named entity 'cough' named entity 'chloroquine' named entity 'Supportive therapy' named entity 'Health Emergencies' named entity 'COVID-19' named entity 'neutropenia' named entity 'COVID' named entity 'Italian' named entity 'Italian' named entity 'CRS' named entity 'in-vitro' named entity 'antiviral therapy' named entity 'thrombocytopenia' named entity 'CT scan' named entity 'SARS-COV-2' named entity 'chloroquine' named entity 'local transmission' named entity 'difficulty breathing' named entity 'the intended' named entity 'SARS' named entity 'National Health Commission' named entity 'Albarello' named entity 'People’s Republic of China' named entity 'chloroquine' named entity 'darunavir' named entity 'oedema' named entity 'the infection' named entity 'PR prolongation' named entity 'respiratory disease' named entity 'remdesivir' named entity 'plasma levels' named entity 'ritonavir' named entity 'COVID' named entity 'concomitant therapy' named entity 'fluid overload'

Attributes

Values

Creator

Ippolito, Giuseppe
Nicastri, Emanuele
Petrosillo, Nicola
D’Offizi, Gianpiero
Lepore, Luciana
Marchioni, Luisa
Murachelli, Silvia
Antinori, Andrea
Mondi, Annalisa
Palmieri, Fabrizio
Ascoli Bartoli, Tommaso

is schema:about of

named entity 'Recommendations'
named entity 'COVID-19'
named entity 'INSTITUTE'
named entity 'INFECTIOUS DISEASES'
named entity '80%'
named entity 'NATIONAL'
named entity 'National Institute'
named entity 'G6PD deficiency'
named entity 'intravenously'
named entity 'Hypersensitivity reaction'
named entity 'chloroquine'
named entity 'Porphyria'
named entity 'anaphylactoid reaction'
named entity 'acute respiratory infection'
named entity 'Lopinavir/ritonavir'
named entity 'Virologic'
named entity 'pneumonia'
named entity 'QT prolongation'
named entity 'clinical symptoms'
named entity 'IL-6'
named entity 'Antiviral therapy'
named entity 'health-care'
named entity 'symptom'
named entity 'Antiviral therapy'
named entity 'COVID'
named entity 'China'
named entity 'drug-drug interactions'
named entity 'chloroquine'
named entity 'inflammation'
named entity 'drug-drug interactions'
named entity 'COVID'
named entity 'China'
named entity 'case report'
named entity 'adverse effects'
named entity 'fever'
named entity 'liver function tests'
named entity 'Italy'
named entity 'IL-6 receptor'
named entity 'adverse effects'
named entity 'chloroquine'
named entity 'neutrophil'
named entity 'heart failure'
named entity 'Italy'
named entity 'cardiac failure'
named entity 'D-dimer'
named entity 'COVID'
named entity 'U.S.'
named entity 'Antinori'
named entity 'vital functions'
named entity 'COVID-19 in the United States'
named entity 'aplastic anemia'
named entity 'Stevens-Johnson syndrome'
named entity 'Galati'
named entity 'seizure threshold'
named entity 'cough'
named entity 'chloroquine'
named entity 'Supportive therapy'
named entity 'Health Emergencies'
named entity 'COVID-19'
named entity 'neutropenia'
named entity 'COVID'
named entity 'Italian'
named entity 'Italian'
named entity 'CRS'
named entity 'in-vitro'
named entity 'antiviral therapy'
named entity 'thrombocytopenia'
named entity 'CT scan'
named entity 'SARS-COV-2'
named entity 'chloroquine'
named entity 'local transmission'
named entity 'difficulty breathing'
named entity 'the intended'
named entity 'SARS'
named entity 'National Health Commission'
named entity 'Albarello'
named entity 'People’s Republic of China'
named entity 'chloroquine'
named entity 'darunavir'
named entity 'oedema'
named entity 'the infection'
named entity 'PR prolongation'
named entity 'respiratory disease'
named entity 'remdesivir'
named entity 'plasma levels'
named entity 'ritonavir'
named entity 'COVID'
named entity 'concomitant therapy'
named entity 'fluid overload'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software